Related Experiment Videos

[Is diet therapy indicated for Crohn disease in remission?]

H Lorenz-Meyer, J W Brandes

Deutsche Medizinische Wochenschrift (1946)

|April 15, 1983

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.

Gut·2001

Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis.

Alimentary pharmacology & therapeutics·1998

Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group).

Scandinavian journal of gastroenterology·1996

Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.

Gut·1996

A comparison of budesonide with prednisolone for active Crohn's disease.

The New England journal of medicine·1994

[Patient oriented, prospective comparative study of three different pump systems for artificial enteral nutrition].

Biomedizinische Technik. Biomedical engineering·1991

See all related articles